Email Updates

Search form

You are here

27 SEPTEMBER 2019 VOLUME 20 ISSUE 37

Media Coverage

  • Over a seven-year period, researchers at the University of North Carolina at Chapel Hill tested six individual antiretroviral drugs via an injectable implant containing three elements: an organic solvent, a polymer, and the specific HIV treatment drugs. Data showed that all six drugs were released from the implant at effective levels for “a sustained amount of time ranging from one month to a year,” reports Medical Express.

    September 27, 2019
    HIV Plus Mag
  • Five things, including the power of good leadership, are behind Rwanda’s remarkable progress toward achieving HIV epidemic control, particularly in attaining high levels of linkage to treatment and viral load suppression among people living with HIV.

    September 27, 2019
    The New Times
  • Knowledge generated by communities is playing a vital role in informing HIV prevention and treatment programmes as health NGO Right to Care gears up to find innovative ways to reach UNAIDS 90-90-90 targets by 2020. These are ambitious treatment targets to help end the AIDS epidemic.

    September 26, 2019
    General
    iAfrica
  • Lifelong drug treatment can prevent the virus leading to AIDS — but it remains dormant and can reawaken if therapy is stopped. But now, scientists in the US believe they have made a breakthrough - discovering "one of the key switches that the HIV field has been searching for three decades to find".

    September 26, 2019
    The Sun
  • On Sept. 24, respected journalist Mark S. King published a powerful article, "Gilead Duped Me into Being Their Mouthpiece. Here's How," about a recent experience in which he was asked by a national HIV organization, AIDS United, to write an editorial for what turned out to be a project initiated by and funded by a pharmaceutical company, Gilead Sciences, that was aimed at influencing the market for their products.

    September 26, 2019
    General
    The BodyPro
  • As of this month, about 11,000 people had been initiated on PrEP since its regulatory approval in 2016. Zimbabwe is a HIV high burden country with thousands of new infections each year which makes the call for urgent, large scale PrEP roll out even more prudent.

    September 25, 2019
    Zimbabwe Chronicle
  • Lack of HIV/AIDS prevention measures suitable for women is said to be putting more women at risk of contracting the virus. SRHR Africa Trust Country Programme Officer, Novice Bamusi, said this during media training and an update on Biomedical HIV Prevention Options Agenda in Blantyre yesterday. He said most HIV prevention methods such as the use of condoms and circumcision put men in control on whether to protect themselves and their partners from contracting the virus.

    September 25, 2019
    General
    The Daily Times
  • Awareness of a pill for “preexposure prophylaxis,” or PrEP, is high for all groups of men who have sex with men. But lower proportions of black and Hispanic men, compared with white men, have actually gotten prescriptions for the drug, which is 99 percent effective at preventing HIV transmission, the study team found.

    September 25, 2019
    Reuters
  • “Nothing is developed for us, without us,” Arianna Lint said as she handed the Centers for Disease Control and Prevention (CDC) director, Robert Redfield, a copy of Positively Trans’ new needs assessment of transgender and gender nonconforming people living with HIV. Lint was joined by a large group of people living with HIV on stage at the United States Conference on AIDS in Washington, D.C., earlier this month to disrupt the opening plenary with Redfield and create a dialogue where there wasn’t one.

    September 25, 2019
    General
    Rewire.News
  • This is the story of the insidious influence of Big Pharma on our HIV/AIDS leadership and policy-making, and how an experienced activist like me was tricked into delivering messages for the HIV pharma giant Gilead Sciences.

    September 25, 2019
    My Fabulous Disease
  • Herpes is one of the most prevalent viruses in humans, but this may not always be the case. Last week, researchers from The University of Pennsylvania reported their most recent success in plans to develop a herpes simplex virus 2 (HSV-2) vaccine. The goal is for this vaccine to work similarly to that currently used to prevent HPV infections, and thus significantly lower the prevalence of herpes infections in future populations.

    September 24, 2019
    General
    Forbes
  • Human papillomavirus (HPV) is often associated with cisgender women because it can cause cervical cancer -- sexually active women are told to get regular HPV tests, and when the HPV vaccine first came out, it was specifically marketed to parents of girls. Prevalence of HPV is high among everyone, however, and a new study suggests that cisgender men who have sex with men (MSM) have similar rates of four high-risk types of HPV as cisgender women, while cisgender men who have sex with cisgender women (MSW) have slightly lower rates.

    September 24, 2019
    The BodyPro
  • The introduction and rapid expansion of a combination of HIV services in four Ugandan fishing communities has led to the significant decline of HIV incidence, new research finds. Around 40 percent of people in these communities are living with HIV where high levels of mobility, transactional sex, multiple sexual partnerships, and alcohol use drive HIV transmission. This, coupled with the presence of large proportions of men who tend to access HIV prevention, testing and treatment services less than women, provides a challenging environment for reducing the number of new infections.

    September 24, 2019
    Avert
  • Jonathan Van Ness is coming forward about the moment he discovered he was HIV-positive. The Queer Eye star talked about the news in an interview with NBC's TODAY on Tuesday and also chatted about its connection to his new memoir, Over The Top.

    September 24, 2019
    General
    Daily Mail
  • A new drug course, lasting just one month, is just as effective as longer regimens at preventing TB, scientists reported earlier this year. The results have left experts hoping for new progress against a disease that has been an intractable enemy for centuries.

    September 23, 2019
    General
    New York Times
  • WHO confirmed that a second investigational Ebola vaccine will be introduced in the ongoing outbreak in the Democratic Republic of the Congo, or DRC, starting in mid-October in an effort to prevent further spread of the virus.

    September 23, 2019
    General
    Healio
  • Previous research has determined that testing for HIV in emergency department settings is an effective way to diagnose individuals with HIV who may be otherwise hard to reach. New research has built upon this and found that jump-starting HIV treatment in the emergency department could be a key to curbing the spread of the virus.

    September 23, 2019
    General
    Contagion Live

Published Research

Announcements